Anti- c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro

Background: Strategies aimed at inhibiting the expression of the c-myc oncogene could provide the basis for alternative cancer treatment. In this regard, silencing c-myc expression using small interfering RNA (siRNA) is an attractive option. However, the development of a clinically viable, siRNA-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Saffiya, Daniels, Aliscia, Ariatti, Mario, Singh, Moganavelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745184/
https://www.ncbi.nlm.nih.gov/pubmed/33391729
http://dx.doi.org/10.12688/f1000research.25142.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745184/
https://www.ncbi.nlm.nih.gov/pubmed/33391729
http://dx.doi.org/10.12688/f1000research.25142.2

Ejemplares similares